Indomethacin and canine lower esophageal sphincter pressure. 1977

R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi

A total of 20 experiments were carried out on 10 dogs to investigate the effect of indomethacin, administered rectally, on the canine lower esophageal sphincter pressure (LESP). Indomethacin increases LESP. Its effect begins 60 minutes after rectal administration and lasts for about 120 minutes. It reaches its highest level 90 minutes after administration. Indomethacin has no effect on the canine fundal or esophageal pressure.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D011312 Pressure A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Pressures
D012007 Rectum The distal segment of the LARGE INTESTINE, between the SIGMOID COLON and the ANAL CANAL. Rectums
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004943 Esophagogastric Junction The area covering the terminal portion of ESOPHAGUS and the beginning of STOMACH at the cardiac orifice. Gastroesophageal Junction,Gastroesophageal Junctions,Junction, Esophagogastric,Junction, Gastroesophageal,Junctions, Gastroesophageal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
September 2002, The Journal of surgical research,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
August 2005, Digestive diseases and sciences,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
February 1970, Gastroenterology,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
April 1989, Surgery,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
April 1994, Digestive diseases and sciences,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
October 1977, The American journal of digestive diseases,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
June 1980, Digestive diseases and sciences,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
April 1990, Digestive diseases and sciences,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
December 1976, The American journal of digestive diseases,
R E Mokka, and L Punto, and M I Kairaluoma, and T K Larmi
January 1974, Surgical forum,
Copied contents to your clipboard!